Cariprazine

Chemical formula: C₂₁H₃₂Cl₂N₄O  Molecular mass: 427.41 g/mol  PubChem compound: 11154555

Therapeutic indications

Cariprazine is indicated for:

Schizophrenia

Population group: only adults (18 - 65 years old)

Cariprazine is indicated for the treatment of schizophrenia in adult patients.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Cariprazine is contraindicated in the following cases:

Strong or moderate inhibitors of CYP3A4

at least one of
Strong CYP3A4 inhibitors
Moderate CYP3A4 inhibitors

Strong and moderate inducers of CYP3A4

at least one of
Strong potency CYP3A4 inducers
Unspecified potency CYP3A4 inducers

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2018: REAGILA Hard capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈